Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UiPath Inc (PATH) vs Procter & Gamble Co (PG) Price & Performance

UiPath IncTrade
Procter & Gamble CoTrade

Price performance (Past 24H)

Key statistics

UiPath Inc vs Procter & Gamble Co — how do they compare? UiPath Inc trades at $10.65 (market cap $6.24B), while Procter & Gamble Co trades at $149.18 (market cap $344.87B). The key difference: Procter & Gamble Co is far larger — about 55.3× UiPath Inc's market cap, and Procter & Gamble Co pays a 2.94% dividend while UiPath Inc pays none. Which is the better fit depends on your goals.

PATHPG
Market Cap
$6.24B$344.87B
Sector
TechnologyConsumer Staples
52-Week High
$19.29$167.18
52-Week Low
$9.38$138.10
Enterprise Value
$5.01B$370.34B
Volume
6,423,436
Dividend Yield
2.94%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

UiPath Inc

UiPath (PATH) trades at $12.04, down 0.91% on the day, with a bullish technical signal from moving averages. The company shows improving fundamentals with revenue growing from $1.43B in 2025 to a projected $1.7B in 2026, while narrowing net losses signal a path toward sustained profitability. Recent news highlights strong annual recurring revenue growth to $1.9B and strategic AI automation developments through its Maestro platform.

The investment outlook is cautiously optimistic, supported by analyst consensus and improving margins, but risks include competitive pressures in AI automation and volatility in software spending. The stock presents a potential opportunity if execution on profitability continues, though near-term earnings misses warrant monitoring.

Procter & Gamble Co

Procter & Gamble (PG) trades at $149.15, showing minimal daily movement. The stock exhibits neutral technical signals with support near $147 and resistance at $150. Fundamentally, PG maintains stable revenue near $84.3 billion and strong net income margins above 19%, supported by consistent earnings beats. Recent news highlights its dividend reliability amid market volatility, with a 69-year track record of increases. Analyst consensus is bullish with a $160.50 price target, though valuation multiples trade at premiums to peers.

PG offers steady growth with dividend safety but faces near-term headwinds from premium valuations and modest revenue expansion. Upside depends on execution of supply chain efficiencies and sustained consumer demand. Risks include competitive pressures and economic sensitivity. Institutional ownership trends show mixed positioning, reflecting cautious optimism.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About UiPath Inc

UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.

Read more on PATH

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Read more on PG